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Available online 24 April 2012In people with CF, intestinal exocrine malfunction, antibi-
otic usage [1] and swallowing of infected respiratory mucus [2]
likely perturb the normal community of commensal bacteria
in the gut. People with CF report various intestinal problems
which may be alleviated by probiotic administration [3].
There is also evidence that probiotic bacteria can help people
with CF fight respiratory infection [4,5]. However, CF-related
gut dysbiosis has only recently been subjected to detailed in-
vestigation. Using DGGE and culture-based methods, Duytscha-
ever and colleagues [6] showed that children with CF have
a quantitatively and qualitatively different faecal microbiota
from their healthy siblings. We conducted a pilot study using
culture-independent stool microbiome profiling and found
evidence consistent with these results, strengthening the case
for more targeted exploration of the gut microbiota in CF.
We obtained stool samples from four people with CF and
four unrelated, healthy, age- and sex-matched controls. Total
DNA was extracted and the 16S rRNA gene amplified. We
analysed bacterial community composition using a high-
density phylogenetic microarray (PhyloChip) that has been
used extensively in microbial ecology surveys, including
analyses of the human gut [7] and CF airways [8]. Full methods
are available as Supplementary Content.
In 3 of 4 pairs the CF patient exhibited lower taxonomic
richness, evenness and diversity than the healthy control
(Fig. 1). Further, non-metric multidimensional scaling [9]
revealed greater inter-individual variation in gut microbiota in
the CF group than in the healthy controls. Given the range of
factors that produce variation in the human gut microbiome it is
impossible within this small cohort to speculate whether this is
simply a function of disease severity and/or antibiotic use, or of
other variables such as host genetics, diet, environment and age.⁎ Corresponding author. Tel.: +44 1865 271100; fax: +44 1865 310447.
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doi:10.1016/j.jcf.2012.03.007Finally, consistent with Duyschaever et al.'s data, we found
decreased relative abundance of Bifidobacterium species in the
CF group; these are widely used in probiotic products and
one of the species with decreased abundance in our cohort,
Bifidobacterium breve, may mediate intestinal homeostasis
[10]. A full list of taxa with altered relative abundance in the
CF group is provided in the Supplementary Content.
While our pilot data set is too small to draw firm conclusions,
our data support the hypothesis that people with CF have intestinal
microbial dysbiosis. This, together with the prophylactic potential
of probiotics for preventing respiratory infections, highlights a
need to investigate the intestinal microbiota of CF in a larger
cohort. In the future this may inform studies that investigate the
prophylactic potential of probiotics for people with CF.Acknowledgements
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Fig. 1. In three of four participant pairs, the microbial community isolated from the individual with CF showed lower species richness, evenness and diversity than
that isolated from the healthy control individual. Evenness measures the relative distribution of community members and diversity is a metric that takes both richness
and evenness into account.
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